AudioCure Pharma – To turn incurable hearing loss into a treatable event
AudioCure Pharma focuses on the development of drug candidates, in particular for disorders of the ear, including acute hearing loss and tinnitus. These indications have a very high unmet clinical need. Our team of scientists are highly experienced specialists in the fields of neurosciences, audiology, drug development and clinical trials.
AudioCure Pharma is a pharmaceutical start-up with a focus on hearing impairments. Our team of specialists is dedicated to the preclinical research and clinical development of novel pharmacotherapies to treat disorders of the inner ear.
In a first step, we are developing a treatment for acute hearing loss. Secondly, we focus on acute tinnitus which affects more than 1% of the population each year. Both these therapies are currently in the preclinical development stage. This field represents a huge medical need as there are no FDA or EMA approved drugs for either indication.
The development of therapies for other disorders of the inner ear (including improvement of cochlear implant connectivity and ototoxicity) as well as the vestibular system (e.g. dizziness and vertigo) will be initiated subsequently.
Learn more about our Drug Pipeline here.